CATALOGO DEI PRODOTTI DELLA RICERCA

Mariotto, Sara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.663
NA - Nord America 5.101
AS - Asia 4.267
SA - Sud America 746
AF - Africa 127
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 15.935
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.980
RU - Federazione Russa 2.937
SG - Singapore 1.754
CN - Cina 1.282
BR - Brasile 621
GB - Regno Unito 583
IT - Italia 508
HK - Hong Kong 403
VN - Vietnam 348
DE - Germania 314
SE - Svezia 302
FR - Francia 295
IE - Irlanda 295
FI - Finlandia 158
KR - Corea 132
CA - Canada 70
AR - Argentina 59
ID - Indonesia 59
JP - Giappone 51
IN - India 49
UA - Ucraina 42
PL - Polonia 40
ES - Italia 38
BE - Belgio 35
ZA - Sudafrica 34
MX - Messico 33
AT - Austria 29
NL - Olanda 29
TG - Togo 29
BD - Bangladesh 28
AU - Australia 25
BJ - Benin 25
TR - Turchia 25
IR - Iran 23
IQ - Iraq 16
LT - Lituania 16
EC - Ecuador 15
UZ - Uzbekistan 15
AE - Emirati Arabi Uniti 13
CL - Cile 12
MA - Marocco 12
PK - Pakistan 12
VE - Venezuela 11
CO - Colombia 8
PY - Paraguay 8
SA - Arabia Saudita 8
EG - Egitto 7
IL - Israele 7
JM - Giamaica 6
KE - Kenya 6
BG - Bulgaria 5
CZ - Repubblica Ceca 5
PE - Perù 5
RO - Romania 5
JO - Giordania 4
LB - Libano 4
LU - Lussemburgo 4
OM - Oman 4
PA - Panama 4
TW - Taiwan 4
UY - Uruguay 4
AZ - Azerbaigian 3
DK - Danimarca 3
GR - Grecia 3
KZ - Kazakistan 3
NP - Nepal 3
RS - Serbia 3
TN - Tunisia 3
AL - Albania 2
CH - Svizzera 2
CI - Costa d'Avorio 2
HU - Ungheria 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
ML - Mali 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
ZM - Zambia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GF - Guiana Francese 1
GM - Gambi 1
GY - Guiana 1
Totale 15.921
Salva come PNG Salva come JPEG
Città #
Moscow 1.022
Singapore 807
Dallas 705
Chandler 689
Ashburn 620
Southend 414
Hong Kong 401
Beijing 292
Dublin 281
New York 163
Woodbridge 157
Verona 152
Los Angeles 144
The Dalles 144
Jacksonville 131
Ann Arbor 111
Ho Chi Minh City 108
Lawrence 98
Princeton 98
Wilmington 85
Helsinki 75
Munich 73
Jinan 71
Dearborn 66
Houston 66
Hanoi 63
Redondo Beach 62
Shenyang 55
Nanjing 53
Redmond 53
Sindelfingen 52
São Paulo 51
London 48
Buffalo 44
Columbus 43
Hebei 43
Santa Clara 43
Tianjin 42
Jakarta 41
Milan 39
Tokyo 39
Warsaw 38
Washington 38
Dong Ket 36
Brussels 34
Seattle 33
Seoul 33
Brooklyn 31
Lomé 29
Nuremberg 29
Guangzhou 28
Phoenix 28
Boardman 27
Changsha 27
Chicago 27
Denver 27
Montreal 27
Ningbo 27
Lappeenranta 26
Turku 26
Cotonou 25
Bologna 24
Zhengzhou 24
Hangzhou 23
Orem 23
Adelaide 22
Nanchang 22
Belo Horizonte 21
Falls Church 21
Taiyuan 21
Council Bluffs 20
Poplar 20
Rio de Janeiro 19
Haikou 18
Johannesburg 18
Kent 18
Toronto 18
Atlanta 16
Redwood City 16
Taizhou 16
Boston 15
Frankfurt am Main 15
Norwalk 15
Haiphong 14
Mexico City 14
San Jose 14
Vienna 14
Bloomsbury 13
Falkenstein 13
Campinas 12
Chennai 12
Rome 12
Stockholm 12
Brasília 11
Fairfield 11
Hefei 11
Hải Dương 11
Lanzhou 11
Menlo Park 11
San Francisco 11
Totale 8.972
Salva come PNG Salva come JPEG
Nome #
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 225
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian Consensus Conference on Pain in Neurorehabilitation 211
Cyclooxygenase 2, toll-like receptor 4 and interleukin 1beta mRNA expression in atherosclerotic plaques of type 2 diabetic patients. 205
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management 203
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 201
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 201
Brentuximab vedotin: axonal microtubule's Apollyon 188
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 187
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 185
Time for a Consensus Conference on pain in neurorehabilitation 183
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 183
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 183
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 180
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 179
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder 175
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report. 168
Neurosyphilis manifesting with rapidly progressive dementia: report of three cases. 166
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 166
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy 165
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 158
Nervous system: subclinical target of SARS-CoV-2 infection 157
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 156
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 155
Acute cervical longitudinally extensive transverse myelitis in a child with Lipopolysaccharide-Responsive-Beige-Like-Anchor-Protein (LRBA) deficiency: a new complication of a rare disease 154
Sural nerve biopsy: current role and comparison with serum neurofilament light chain levels 152
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 148
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome 147
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 145
Antibodies to MOG in CSF only: pathological findings support the diagnostic value 143
Anti-MOG-associated demyelinating disorders: two sides of the same coin 141
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 139
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 139
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series 138
The original histological slides of Camillo Golgi and his discoveries on neuronal structure 137
Hypothalamic-Bulbar MRI hyperintensity in Anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature 132
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 132
GABA(A) receptor autoimmunity after alemtuzumab treatment for multiple sclerosis 131
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 130
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 130
Oligoclonal bands: clinical utility and interpretation cues 130
HCV-related nervous system disorders. 129
Gender disparity in editorial boards of journals in neurology 129
Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings 128
Application of the international criteria for optic neuritis in the Acute Optic Neuritis Network 124
Autoimmune encephalitis misdiagnosis and mimics 124
Inter-center agreement in the interpretation of oligoclonal bands 124
Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study 122
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review 121
Clinical Neuropathology image 1-2018: Golgi silver staining, the black reaction 121
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 121
Cognitive Profile in Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparative Study With Multiple Sclerosis 118
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 118
Is there a correlation between MOGAD and SARS-CoV-2 infection? 118
A score that predicts aquaporin-4-IgG positivity in patients with longitudinally extensive transverse myelitis 117
Autoimmune movement disorders complicating treatment with immune checkpoint inhibitors 115
Neurofilament light chain levels in patients with antibodies to myelin oligodendrocyte glycoprotein (MOG-Abs) 115
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 113
Peripheral neuropathy and central nervous system involvement in cryoglobulinenia. 113
Autoimmune encephalitis: a retrospective monocentric experience 112
Mechanisms of nerve damage in neuropathies associated with hematological diseases: lesson from nerve biopsies 111
l-dopa-induced off: functional overlay in Parkinson disease 110
The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis 109
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 109
GFAP as a marker of astrocytic damage correlated with medication overuse in migraine 108
Brain stimulation as a therapeutic tool in Amyotrophic Lateral Sclerosis: current status and interaction with mechanisms of altered cortical excitability 108
Infectious neuropathies 107
Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis 106
Cerebrospinal fluid analysis and the determination of oligoclonal bands 105
Review of West Nile virus epidemiology in Italy and report of a case of West Nile virus encephalitis. 104
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 101
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD) 100
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD, a literature review 99
SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study 99
HCV-related central and peripheral nervous system demyelinating disorders. 99
Exposure to TNF inhibitors is rare at MOGAD presentation 99
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 99
Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens 97
Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers 96
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations 95
Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy 95
A novel cell-based immunofluorescence assay for the detection of autoantibodies to myelin-associated glycoprotein 95
Peripheral neuropathy and MOG-IgG: a clinical and neuropathological retrospective study 94
Cerebellar involvement associated with immune checkpoint inhibitors: a systematic review 94
Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease 93
Brentuximab vedotin-induced peripheral neuropathy: looking at microtubules 93
NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders 93
Sporadic Creutzfeldt-Jakob disease: prion pathology in medulla oblongata-possible routes of infection and host susceptibility. 92
Superior diagnostic performance of reduced-FOV DWI versus conventional DWI MRI in anti-NMDAR encephalitis 92
Peripheral neuropathies during the COVID-19 pandemic: is there a relation? 92
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status 91
Diagnostics of dysimmune peripheral neuropathies 91
Serum neurofilament to Magnetic Resonance Imaging lesion area ratio differentiates spinal cord infarction from acute myelitis 91
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder 90
Diagnostics of paraneoplastic neurological syndromes 90
Brain Volume Measures in Adults with MOG-Antibody-Associated Disease: A Longitudinal Multicenter Study 89
Diagnostics of anti-MAG antibody polyneuropathy 89
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 89
Ophthalmoparesis mimicking myasthenia gravis as acute manifestation of Hashimoto’s encephalopathy 88
Investigating the association between neoplasms and MOG antibody-associated disease 88
Serum neurofilament light chain studies in neurological disorders, hints for interpretation 87
Totale 12.807
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.227
article - articoli 58.729
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 393
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.105
Totale 120.454
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021304 0 0 0 0 0 61 28 18 45 10 73 69
2021/2022864 57 266 2 119 19 32 15 37 32 37 71 177
2022/20231.939 115 188 160 343 141 470 25 131 232 33 63 38
2023/20241.279 47 82 137 136 112 304 56 76 21 71 167 70
2024/20253.180 149 198 120 493 155 117 188 199 534 245 258 524
2025/20266.907 647 675 639 1.612 2.775 559 0 0 0 0 0 0
Totale 16.215